It’s been a long road, but the Olympic torch finally landed in Japan on 23 July. The latest edition of the Games has been so… Read More »TOKYO 2020: HOW CANNABIS HAS CHANGED THE OLYMPIC GAMES

As Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals says: “We have now executed four of five planned product launches since the beginning… Read More »Jazz Pharma Reports Pro Forma Epidiolex Sales Grew 32% to $156 Million in Q2

UK tobacco giant BAT has followed up its £127m investment into Organigram with further investment in a Canadian cannabis company. Research-based Trait Biosciences says it has completed a… Read More »UK Tobacco Giant BAT Makes Third Cannabis Investment As It Moves Beyond Nicotine

Click below to browse data bases provided by Daily Marijuana Observer. MORE

Curaleaf, the largest cannabis company in the U.S., is on its way to become the largest of its kind in the world after announcing a $286… Read More »Curaleaf To Expand To Europe With $286 Million Acquisition, Eyes Eastern Europe And Africa Next

On 22/06/2021, Arek Kuich – partner of our company – gave a speech titled “Opportunities for Entering or Investing in the Polish Medical Cannabis Market”… Read More »Arek Kuich spoke at Cannabis Business Europe in Frankfurt

The Polish government has tentatively agreed to increase the THC limit for industrial hemp from the current 0.2% to 0.3%. The preliminary accord was reached… Read More »Poland near accord on raising hemp THC level to 0.3%

Tilray Inc. TLRY, +0.49% shareholders voted to approve the Canadian cannabis company’s proposed merger with Aphria Inc. aphaca:apha at a special meeting on Friday, according to media reports, paving the… Read More »Tilray shareholders approve Aphria merger, creating world’s biggest cannabis company by revenue

New Frontier Data has previously reported about the varied applications for hemp. From Europe’s strong processing infrastructure and finished-goods industry, to a broad range of consumable products,… Read More »Pets May Offer Dogged Potential for European CBD Market Share

With the rapidly growing pandemic of COVID-19 caused by the new and challenging to treat zoonotic SARS-CoV2 coronavirus, there is an urgent need for new… Read More »Novel Anti-Inflammatory High-CBD Cannabis Sativa Extracts Modulate ACE2 Expression in COVID-19 Gateway Tissues